Results 171 to 180 of about 22,108 (285)

Predictive Value of Computed Tomographic Ethmoid-to-Maxillary Ratio in Patients with Chronic Rhinosinusitis and Nasal Polyp. [PDF]

J Asthma Allergy
Wu PW, Wei ZH, Huang CC, Chang PH, Lee TJ, Huang CC.   +5 more
europepmc   +1 more source

Complement–Eosinophil Crosstalk Links Complement Activation to Fibrin Deposition in Eosinophilic Chronic Rhinosinusitis

Allergy, EarlyView.
Ryo Hasegawa, Shigeharu Ueki, Misaki Arima, Shohei Nishiyama, Keinosuke Hizuka, Kohei Tatsumi, Ayako Sawai, Anna Shimizu, Yuki Sonoda, Eiichi Kato, Masanori Kidoguchi, Masafumi Sakashita, Yohei Sato, Atsushi Kato, Bruce K. Tan, Robert C. Kern, Robert P. Schleimer, Shigeharu Fujieda, Yoshimasa Imoto   +18 more
wiley   +1 more source

Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)

International Forum of Allergy &Rhinology, Volume 16, Issue 5, Page 484-494, May 2026.
ABSTRACT Background Loss of smell is a principal symptom of chronic rhinosinusitis with nasal polyps (CRSwNP), affecting health‐related quality of life and posing a safety hazard. Methods WAYPOINT (NCT04851964), a phase 3, multicenter trial in adults with uncontrolled CRSwNP, randomized patients 1:1 to receive tezepelumab 210 mg or placebo ...
Joaquim Mullol, Joseph K. Han, Tanya M. Laidlaw, Claire Hopkins, Anju T. Peters, Oliver Pfaar, Martin Desrosiers, Stella E. Lee, Andrew P. Lane, Claudia Chen, Yun Chon, Sandhia S. Ponnarambil, Andrew Foster, Andrew W. Lindsley, Christopher S. Ambrose   +14 more
wiley   +1 more source

Full Clinical Pathological and Bacteriological Investigation of a Giant Nasal Polyp Associated With the Developing Apex of the Permanent Fourth Premolar (Triadan 108) in a 3-year-old Connemara Filly: A Case Report. [PDF]

Vet Med Sci
Sidwell A, Shanklin A, Miller H, Cahoon M, Hole SL, Bianco C, Pereira R.   +6 more
europepmc   +1 more source

Functional Endoscopic Sinus Surgery in Adults With CRSwNP Treated With Mepolizumab: Airway Physiology Outcomes From a Randomised Controlled Trial

Clinical &Experimental Allergy, EarlyView.
Jens Tidemandsen, Anne Sophie Homøe, Peter G. Gibson, Howraman Meteran, Kasper Aanæs, Morten Hostrup, Marie Høxbro, Vibeke Backer   +7 more
wiley   +1 more source

Multiple Myeloma Presenting as Lower Gastrointestinal Bleeding: A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Multiple myeloma (MM) is a malignant hematologic neoplasm that primarily affects the bone marrow and can invade other organs, leading to diverse clinical manifestations. Presentation with gastrointestinal bleeding as the initial symptom is exceptionally rare.
Ahmed Arabi, Naseem Ambra, Asgad Mohamed Ahmed Eltigani, Asma Ahmed Yousif, Abdelkarim Hashim Mohamed   +4 more
wiley   +1 more source

Inflammatory and homeostatic roles of eosinophil subpopulations in chronic rhinosinusitis with nasal polyp pathogenesis. [PDF]

Front Immunol
Simmalee K, Lumjiaktase P, Kawamatawong T, Guemari A, Dormoy V, Vitte J.   +5 more
europepmc   +1 more source

Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth. [PDF]

Ann Allergy Asthma Immunol, 2023
Supron AD, Bergmark RW, Roditi RE, Buchheit KM.   +3 more
europepmc   +1 more source

Less Can Be Enough: Sustained Remission of Pediatric Eosinophilic Esophagitis With Low‐Frequency Dupilumab

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Eosinophilic esophagitis (EoE) is a chronic, immune‐mediated disease requiring long‐term therapy. Dupilumab, an interleukin‐4 and interleukin‐13 receptor antagonist, is approved for EoE at a weekly 300 mg dosing regimen. However, data on reduced‐frequency dosing, especially in pediatric patients, remain limited.
Giovanni Scatigna, Annarita Iadecola, Martina Piersanti, Giovanni Di Nardo, Maurizio Mennini   +4 more
wiley   +1 more source

Microbiome and Th cytokines association in chronic rhinosinusitis with or without nasal polyp. [PDF]

Laryngoscope Investig Otolaryngol, 2023
Zhu Z, Lan J, Wei R, Xu Y, Hong Y, Bao W, He G.   +6 more
europepmc   +1 more source